Trial: 202012018

Phase II study of short course FOLFOX
chemotherapy with either Nivolumab or Nivolumab + Radiation in the first line treatment of metastatic or
unresectable gastroesophageal cancers (BMS Protocol CA209-76L)

Phase

II

Principal Investigator

Park, Haeseong

Disease Site

Esophagus; Stomach

Learn more about this study at: clinicaltrials.gov